FR2345452B1 - - Google Patents

Info

Publication number
FR2345452B1
FR2345452B1 FR7709107A FR7709107A FR2345452B1 FR 2345452 B1 FR2345452 B1 FR 2345452B1 FR 7709107 A FR7709107 A FR 7709107A FR 7709107 A FR7709107 A FR 7709107A FR 2345452 B1 FR2345452 B1 FR 2345452B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7709107A
Other versions
FR2345452A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3340176A external-priority patent/JPS52122386A/ja
Priority claimed from JP5029576A external-priority patent/JPS52133997A/ja
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of FR2345452A1 publication Critical patent/FR2345452A1/fr
Application granted granted Critical
Publication of FR2345452B1 publication Critical patent/FR2345452B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR7709107A 1976-03-25 1977-03-25 Procede de preparation d'arylmalonamido-1-oxadethiacephalosporines et nouveaux produits ainsi obtenus, a activite antibacterienne Granted FR2345452A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP3340176A JPS52122386A (en) 1976-03-25 1976-03-25 Cephalosporin analogous compounds as antibacterials
JP5029576A JPS52133997A (en) 1976-04-30 1976-04-30 Cephalosporin antibiotics
AU53625/79A AU528617B2 (en) 1976-03-25 1979-12-07 1-oxadethia-cephalosporin antibiotics
AU57286/80A AU531661B2 (en) 1976-03-25 1980-04-09 1-oxadethia-cephalosporins

Publications (2)

Publication Number Publication Date
FR2345452A1 FR2345452A1 (fr) 1977-10-21
FR2345452B1 true FR2345452B1 (fr) 1980-07-25

Family

ID=27423456

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7709107A Granted FR2345452A1 (fr) 1976-03-25 1977-03-25 Procede de preparation d'arylmalonamido-1-oxadethiacephalosporines et nouveaux produits ainsi obtenus, a activite antibacterienne

Country Status (9)

Country Link
US (2) US4138486A (fr)
AT (1) AT353959B (fr)
AU (4) AU510169B2 (fr)
BE (1) BE852912A (fr)
CA (1) CA1085392A (fr)
CH (1) CH629208A5 (fr)
FR (1) FR2345452A1 (fr)
GB (1) GB1547351A (fr)
NL (1) NL176074C (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
CA1085392A (fr) * 1976-03-25 1980-09-09 Masayuki Narisada Arylmalonamido-1-oxadethiacephalosporines
GB1557552A (en) * 1977-02-15 1979-12-12 Shionogi & Co 1 oxadethiacepham compounds
US4443598A (en) * 1977-02-15 1984-04-17 Shionogi & Co., Ltd. 1-Oxadethiacepham compounds
US4478997A (en) * 1977-02-15 1984-10-23 Shionogi & Co., Ltd. 1-Oxadethiacepham compounds
CA1100962A (fr) * 1977-04-28 1981-05-12 Yoshio Hamashima Haloarylmalonamidooxacephalosporines
JPS5419990A (en) * 1977-07-14 1979-02-15 Shionogi & Co Ltd Dihydrotriazinylthioxacephalosporin
JPS609718B2 (ja) * 1977-08-25 1985-03-12 塩野義製薬株式会社 チアジアゾリルチオセフアロスポリン類縁抗生物質
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process
US4252953A (en) * 1979-05-01 1981-02-24 Eli Lilly And Company Antibiotic crystalline epimer
JPS5690088A (en) * 1979-11-02 1981-07-21 Meiji Seika Kaisha Ltd Novel cephalosporin analog compound
JPS56103185A (en) * 1980-01-22 1981-08-18 Shionogi & Co Ltd Malonamidoxa-dethia-cephem compound
US4452778A (en) * 1980-03-31 1984-06-05 Eli Lilly And Company Synergistic antibacterial compositions and method of treatment of infections caused by multiple antibiotic-resistant organisms
US4304774A (en) * 1980-09-17 1981-12-08 Eli Lilly And Company Bis-tetrazolmethyl substituted β-lactam antibiotics
US4301282A (en) * 1980-09-17 1981-11-17 Eli Lilly And Company 1-Oxa-β-lactam antibiotics
US4368156A (en) * 1981-03-09 1983-01-11 Eli Lilly And Company Preparation of 4-haloazetidin-2-ones from 4-sulfinoazetidin-2-ones
EP0067517B1 (fr) * 1981-05-14 1986-02-26 Beecham Group Plc Procédé de préparation d'un énantiomère d'un dérivé béta-lactame
JPS5857360A (ja) * 1981-10-01 1983-04-05 Ajinomoto Co Inc アゼチジノン誘導体
US4391975A (en) * 1981-12-15 1983-07-05 Queen's University At Kingston Process for 1-oxacephem derivatives
US4594247A (en) * 1981-12-21 1986-06-10 Eli Lilly And Company Synergistic antibacterial compositions and method of treatment of infections caused by multiple antibiotic-resistant organisms
US4552763A (en) * 1981-12-21 1985-11-12 Eli Lilly And Company Synergistic antibacterial compositions and method of treatment of infections caused by multiple antibiotic-resistant organisms
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
US4472576A (en) * 1982-12-03 1984-09-18 Merck & Co., Inc. Processes for the production of antibiotic 1-oxadethiacephalosporins
JPS59152385A (ja) * 1983-02-17 1984-08-31 Shionogi & Co Ltd ヒドロキサム酸系セフアロスポリン誘導体
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
JPS60123490A (ja) * 1983-12-07 1985-07-02 Shionogi & Co Ltd マロニルオキサセフェムカルボン酸誘導体
SK13897A3 (en) 1996-02-06 1998-05-06 Pliva Pharm & Chem Works 3-bromo- and 3,3-dibromo-4-oxo-1-azetidines, method for preparation thereof and their use
WO2001012184A1 (fr) 1999-08-16 2001-02-22 Revaax Pharmaceuticals, Llc Composition neurotherapeutique et procede associe
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
US6489319B2 (en) * 1999-08-16 2002-12-03 Revaax Pharmaceuticals, Llc Neurotherapeutic use of carboxypeptidase inhibitors
KR20050083971A (ko) * 2002-11-22 2005-08-26 더 존스 홉킨스 유니버시티 인지능 손상의 치료를 위한 표적
CA2758029A1 (fr) * 2009-04-29 2011-11-04 Rexahn Pharmaceuticals, Inc. Formulation de clavulanate pour une neuroprotection et un traitement de troubles neurodegeneratifs
CN102260280A (zh) * 2010-05-28 2011-11-30 上海医药工业研究院 拉氧头孢钠的制备方法
CN102603784B (zh) * 2012-04-06 2014-12-31 浙江惠迪森药业有限公司 一种拉氧头孢氯化铝(锡)苯甲醚络合物及其制备方法和应用
CN102827191B (zh) * 2012-09-24 2015-03-11 浙江东邦药业有限公司 一种氧头孢类化合物的制备方法
CN107383066A (zh) * 2017-07-31 2017-11-24 山西千岫制药有限公司 一种拉氧头孢酸去保护基的方法
KR102115644B1 (ko) * 2017-09-13 2020-05-27 주식회사 동도물산 7α-알콕시옥사세펨 중간체의 제조방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1914366U (de) 1965-01-08 1965-04-22 Otto Liebmann Fa Schutzhuelle fuer zigarettenschachteln oder -packungen.
US3769277A (en) * 1970-01-23 1973-10-30 Glaxo Lab Ltd Preparation of delta3-4 carboxy cephalosporins having a 3-vinyl or substituted 3-vinyl group
US3728342A (en) * 1970-12-03 1973-04-17 Lilly Co Eli 3-acyloxymethyl cephalosporins and method of preparation
US3795672A (en) * 1971-06-09 1974-03-05 Lilly Co Eli Process for the preparation of delta2-cephem-4-carboxylic acid esters
NL178005C (nl) 1972-11-06 1986-01-02 Merck & Co Inc Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking, alsmede werkwijze ter bereiding van een cefalosporine-antibioticum.
NL7314706A (fr) 1972-11-06 1974-05-08
GB1510794A (en) * 1974-08-06 1978-05-17 Univ Kingston 1-oxacephems and intermediates therefor
US4011216A (en) * 1975-04-11 1977-03-08 Bristol-Myers Company Δ2,3-0-2-Isocephem-4-carboxylic acid and derivatives thereof as antibacterial agents
US4013648A (en) * 1975-07-23 1977-03-22 Bristol-Myers Company Δ2,3 -0-2-Isocephem-4-carboxylic acid and derivatives as antibacterial agents
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
CA1085392A (fr) * 1976-03-25 1980-09-09 Masayuki Narisada Arylmalonamido-1-oxadethiacephalosporines

Also Published As

Publication number Publication date
CH629208A5 (de) 1982-04-15
AU527733B2 (en) 1983-03-17
NL176074C (nl) 1985-02-18
FR2345452A1 (fr) 1977-10-21
CA1085392A (fr) 1980-09-09
AU5362579A (en) 1980-05-01
AU5362479A (en) 1980-05-01
AU5728680A (en) 1980-06-19
AU528617B2 (en) 1983-05-05
NL176074B (nl) 1984-09-17
AU510169B2 (en) 1980-06-12
AU2350877A (en) 1978-09-28
NL7703282A (nl) 1977-09-27
BE852912A (fr) 1977-09-26
US4323567A (en) 1982-04-06
GB1547351A (en) 1979-06-13
AT353959B (de) 1979-12-10
AU531661B2 (en) 1983-09-01
ATA205777A (de) 1979-05-15
US4138486A (en) 1979-02-06

Similar Documents

Publication Publication Date Title
FR2345452B1 (fr)
DK142252C (fr)
DK141392C (fr)
DK137650C (fr)
FR2360843B3 (fr)
JPS5742047B2 (fr)
DE2615739C2 (fr)
FR2362607B1 (fr)
FR2373081B3 (fr)
JPS52143314U (fr)
JPS5333412Y2 (fr)
JPS5534310B2 (fr)
JPS5333932U (fr)
JPS5341911U (fr)
JPS5393245U (fr)
DE2637745C2 (fr)
JPS5552519Y2 (fr)
JPS5393653U (fr)
JPS5375901U (fr)
DK67176A (fr)
FI760115A (fr)
JPS52164022U (fr)
BG23506A1 (fr)
BG23277A1 (fr)
CH595430A5 (fr)

Legal Events

Date Code Title Description
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0460, 920618

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0460, 770325

CL Concession to grant licences
ST Notification of lapse